West Pharmaceutical Services EBIT 2010-2024 | WST

West Pharmaceutical Services EBIT for the quarter ending June 30, 2024 was $0.126B, a 30.85% decline year-over-year.

  • West Pharmaceutical Services 2023 EBIT was 0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services 2022 EBIT was 0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services 2021 EBIT was 0.752B, a 84.89% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

West Pharmaceutical Services EBIT 2010-2024 | WST

  • West Pharmaceutical Services 2023 EBIT was 0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services 2022 EBIT was 0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services 2021 EBIT was 0.752B, a 84.89% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$66.8B
McKesson (MCK)$66.6B
Cardinal Health (CAH)$26.9B
Cooper (COO)$21.9B
Labcorp (LH)$19.1B
Align Technology (ALGN)$18.9B
Henry Schein (HSIC)$9B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$125M
Pro-Dex (PDEX)$83M